<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab3">
 <label>Table 3</label>
 <caption>
  <p>Incidence of virus-associated acute lower respiratory infections in children aged 2–23 months from February to December 2015 in the Basse HDSS, rural Gambia; (mid-point population at risk: 2–11 mo = 5038, 12–23 mo = 6254).</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Age 2–11 mo</th>
    <th>Observed number of cases</th>
    <th>Expected number of cases (95% CI)</th>
    <th>Expected incidence per 1000 population per year (95% CI)</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Any virus</td>
    <td>196</td>
    <td>991 (913, 1066)</td>
    <td>197 (181, 212)</td>
   </tr>
   <tr>
    <td>RSV-A</td>
    <td>165</td>
    <td>847 (765, 927)</td>
    <td>168 (152, 184)</td>
   </tr>
   <tr>
    <td>RSV-B</td>
    <td>3</td>
    <td>14 (0, 35)</td>
    <td>3 (0, 7)</td>
   </tr>
   <tr>
    <td>Influenza-A</td>
    <td>9</td>
    <td>51 (21, 85)</td>
    <td>10 (4, 17)</td>
   </tr>
   <tr>
    <td>Influenza-B</td>
    <td>6</td>
    <td>31 (8, 59)</td>
    <td>6 (2, 12)</td>
   </tr>
   <tr>
    <td>PIV-1</td>
    <td>1</td>
    <td>6 (0, 20)</td>
    <td>1 (0, 4)</td>
   </tr>
   <tr>
    <td>PIV-3</td>
    <td>10</td>
    <td>47 (19, 81)</td>
    <td>9 (4, 16)</td>
   </tr>
   <tr>
    <td>PIV-4</td>
    <td>10</td>
    <td>35 (12, 62)</td>
    <td>7 (2, 12)</td>
   </tr>
   <tr>
    <td colspan="4">
     <bold>Age 12–23 mo</bold>
    </td>
   </tr>
   <tr>
    <td>Any virus</td>
    <td>107</td>
    <td>561 (494, 626)</td>
    <td>90 (79, 100)</td>
   </tr>
   <tr>
    <td>RSV-A</td>
    <td>72</td>
    <td>389 (321, 457)</td>
    <td>62 (51, 73)</td>
   </tr>
   <tr>
    <td>RSV-B</td>
    <td>4</td>
    <td>22 (3, 47)</td>
    <td>4 (0.5, 8)</td>
   </tr>
   <tr>
    <td>Influenza-A</td>
    <td>10</td>
    <td>54 (23, 91)</td>
    <td>9 (4, 15)</td>
   </tr>
   <tr>
    <td>Influenza-B</td>
    <td>14</td>
    <td>74 (37, 115)</td>
    <td>12 (6, 18)</td>
   </tr>
   <tr>
    <td>PIV-1</td>
    <td>0</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>PIV-3</td>
    <td>6</td>
    <td>28 (7, 55)</td>
    <td>4 (1, 9)</td>
   </tr>
   <tr>
    <td>PIV-4</td>
    <td>6</td>
    <td>33 (8, 64)</td>
    <td>5 (1, 10)</td>
   </tr>
   <tr>
    <td colspan="4">
     <bold>Age 2–23 mo</bold>
    </td>
   </tr>
   <tr>
    <td>Any virus</td>
    <td>303</td>
    <td>1543 (1439, 1644)</td>
    <td>140 (131, 149)</td>
   </tr>
   <tr>
    <td>RSV-A</td>
    <td>237</td>
    <td>1232 (1124, 1339)</td>
    <td>112 (102, 122)</td>
   </tr>
   <tr>
    <td>RSV-B</td>
    <td>7</td>
    <td>34 (10, 65)</td>
    <td>3 (1, 6)</td>
   </tr>
   <tr>
    <td>Influenza-A</td>
    <td>19</td>
    <td>97 (55, 144)</td>
    <td>9 (5, 13)</td>
   </tr>
   <tr>
    <td>Influenza-B</td>
    <td>20</td>
    <td>104 (60, 154)</td>
    <td>9 (5, 14)</td>
   </tr>
   <tr>
    <td>PIV-1</td>
    <td>1</td>
    <td>5 (0, 18)</td>
    <td>0.5 (0, 2)</td>
   </tr>
   <tr>
    <td>PIV-3</td>
    <td>16</td>
    <td>77 (40, 120)</td>
    <td>7 (4, 11)</td>
   </tr>
   <tr>
    <td>PIV-4</td>
    <td>16</td>
    <td>67 (33, 107)</td>
    <td>6 (3, 10)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>Note:</italic> Values for the expected and 95% confidence limits for the number of cases in the population took into account the monthly sampling scheme, being generated by simulation using the number of observed cases each month, the number of patients tested each month and the proportion of all patients tested each month (see Methods and Supplementary Tables 
   <xref rid="MOESM1" ref-type="media">11</xref>–
   <xref rid="MOESM1" ref-type="media">13</xref> and Supplementary Material p 
   <xref rid="MOESM1" ref-type="media">19)</xref>. Expected numbers of cases by simulation in age strata may not sum to the expected number of cases overall.
  </p>
 </table-wrap-foot>
</table-wrap>
